Services & Products
Recombinant Antibody Expression
Photo of process
Eureka Therapeutics provides services for the production, purification, and characterization of monoclonal antibodies in amounts ranging from 1-2 mg to 1-10 grams. The products are certified to possess low endotoxin and nucleic acid levels suitable for preclinical animal studies.

Eureka's state-of-the-art facilities and technical expertise enable the production of 1-2 mgs of recombinant antibodies in mammalian system within 30 days. Production can be scaled-up to 100-200 mg (or 1-10 grams) within 150 days.

All produced materials are assayed for purity, activity, endotoxin, and nucleic acid levels to meet defined criteria.

Please contact services@eurekainc.com for more details and service quotes.